Employee-related Liabilities, Current of PharmaCyte Biotech, Inc. from 30 Apr 2014 to 31 Jul 2023

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
PharmaCyte Biotech, Inc. quarterly Employee-related Liabilities, Current in USD history and change rate from 30 Apr 2014 to 31 Jul 2023.
  • PharmaCyte Biotech, Inc. Employee-related Liabilities, Current for the quarter ending 31 Jul 2023 was $134,630, a 9.4% decline year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $134,630 -$13,951 -9.4% 31 Jul 2023 10-Q 18 Sep 2023 2024 Q1
Q1 2023 $112,894 -$5,168 -4.4% 30 Apr 2023 10-Q 18 Sep 2023 2024 Q1
Q4 2022 $89,697 +$39,597 +79% 31 Jan 2023 10-Q 16 Mar 2023 2023 Q3
Q3 2022 $66,500 +$39,400 +145% 31 Oct 2022 10-Q 14 Dec 2022 2022 Q2
Q2 2022 $148,581 -$361,212 -71% 31 Jul 2022 10-Q 14 Sep 2022 2023 Q1
Q1 2022 $118,062 -$372,842 -76% 30 Apr 2022 10-K 31 Jul 2023 2023 FY
Q4 2021 $50,100 -$434,362 -90% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q3
Q3 2021 $27,100 -$435,681 -94% 31 Oct 2021 10-Q 14 Dec 2021 2022 Q2
Q2 2021 $509,793 +$65,887 +15% 31 Jul 2021 10-Q 14 Sep 2021 2022 Q1
Q1 2021 $490,904 +$55,327 +13% 30 Apr 2021 10-K 28 Jul 2022 2022 FY
Q4 2020 $484,462 31 Jan 2021 10-Q 12 Mar 2021 2021 Q3
Q3 2020 $462,781 31 Oct 2020 10-Q 11 Dec 2020 2021 Q2
Q2 2020 $443,906 +$61,406 +16% 31 Jul 2020 10-Q 11 Sep 2020 2021 Q1
Q1 2020 $435,577 +$76,961 +21% 30 Apr 2020 10-K 10 Aug 2021 2021 FY
Q2 2019 $382,500 31 Jul 2019 10-Q 13 Sep 2019 2020 Q1
Q1 2019 $358,616 +$74,712 +26% 30 Apr 2019 10-K 13 Aug 2020 2020 FY
Q1 2018 $283,904 +$77,038 +37% 30 Apr 2018 10-K 13 Aug 2019 2019 FY
Q1 2017 $206,866 +$131,989 +176% 30 Apr 2017 10-K 20 Jul 2018 2018 FY
Q1 2016 $74,877 +$55,338 +283% 30 Apr 2016 10-K 27 Jul 2017 2017 FY
Q1 2015 $19,539 +$19,539 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q1 2014 $0 30 Apr 2014 10-K/A 19 Jan 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.